Sponsored by
This study showed that it is relatively safe and feasible to do repeated convection enhanced delivery of drugs to the brain - particularly the pons. The drug they used, MTX110 is a nanoparticle formulation of Panobinostat. This was a dose escalation study - so most patients did not get an effective dose - but it still showed an improvement in survival compared to what we know about the outcome of this disease.